%0 Journal Article
%T Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication
%A Damasceno N
%A Horowitz S
%A Damasceno E
%J Clinical Ophthalmology
%D 2012
%I 
%R http://dx.doi.org/10.2147/OPTH.S31239
%X nterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication Case report (1487) Total Article Views Authors: Damasceno N, Horowitz S, Damasceno E Published Date July 2012 Volume 2012:6 Pages 1201 - 1205 DOI: http://dx.doi.org/10.2147/OPTH.S31239 Received: 27 February 2012 Accepted: 17 April 2012 Published: 31 July 2012 Nadyr Damasceno,1 Soraya Horowitz,2 Eduardo Damasceno3 1,2Ophthalmology Department, Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil; 3Department of Ophthalmology, Universidade Federal Fluminense, Niteroi, Brazil Abstract: The authors describe one case of anterior uveitis after treatment of age-related macular degeneration with both antiangiogenic drugs: ranibizumab and bevacizumab. The case is described as a complication of ranibizumab and bevacizumab due to an inflammatory process. Several reasons are suggested to explain this possibility, and the authors conclude that the main cause remains unknown.
%K antiangiogenic agent
%K complications
%K ocular inflammatory process
%K ranibizumab
%K bevacizumab
%K anterior uveitis
%U https://www.dovepress.com/anterior-uveitis-after-treatment-of-age-related-macular-degeneration-w-peer-reviewed-article-OPTH